A randomised control experiment comparing the efficacy of traditional treatment for nail thickening issues with customised nail patches containing urea, glycerin, salicylic acid, and biotin

Effectiveness of customized nail patches containing Urea, Glycerin, Salicylic acid and Biotin versus conventional treatment in disorders of nail thickening: A randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078603

Enrollment

Registered

2024-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L62- Nail disorders in diseases classified elsewhere

Interventions

Intervention1: Customized nail patch containing Urea, Glycerin, Salicylic acid and Biotin: Customized nail patches containing- Urea (40%), Glycerin (30%), Salicylic acid (20%) and Biotin will be appli

Eligibility

Inclusion criteria

Inclusion criteria: Consenting patients within age 18-65 years having more than or equal to 2 nail thickening will be included

Exclusion criteria

Exclusion criteria: 1.Children below the age of 18 years 2.Pregnancy or Lactating women 3.Participants with known allergies to any of the ingredients present in the nail patch 4.Individuals taking medications that may interact with the active ingredients in the nail patches or affect nail health 5.Individuals who have undergone recent nail procedures such as nail surgery, nail avulsion, or chemical nail treatments.

Design outcomes

Primary

Measure	Time frame
Overall improvement in thickness and colour of nail in disorders of nail thickeningTimepoint: 4,8 and 12 weeks	—

Secondary

Measure	Time frame
Using a visual analog scale patients satisfaction with treatment was assessedTimepoint: 4,8 & 12 weeks	—

Countries

India

Contacts

Public ContactDr Abyramy Balasundaram

Saveetha Medical College and Hospital

b.abyramy@gmail.com7598566974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026